Impact of Mindful Awareness Practices in Pediatric Residency Training

Sponsor
University of California, Los Angeles (Other)
Overall Status
Completed
CT.gov ID
NCT03613441
Collaborator
(none)
82
1
2
10.9
7.5

Study Details

Study Description

Brief Summary

This study evaluates the effect of a standardized mindfulness based intervention compared to control on self-reported levels of stress in residency trainees.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindful Awareness Practices (MAPs)
N/A

Detailed Description

Recent research studies have indicated that the practice of mindfulness is strongly correlated with enhanced well-being and improved resilience in a variety of populations. Mindfulness-based interventions have been shown to reduce stress and symptoms of burnout in physicians. However, the two studies that included residents were observational trials evaluating the effect of an abbreviated, informal mindfulness course.

The aim of the investigator's study is to assess whether a standardized course in mindfulness meditation (Mindful Awareness Practices, MAPs) reduces self--reported signs and symptoms of stress, burnout, depression, anxiety, loneliness and poor sleep quality in residents in pediatrics training. This study is a randomized controlled trial using 2 parallel groups. The pediatrics residents randomized to the intervention will participate in a standardized mindful awareness practices intervention consisting of one live 45- minute session and 5 web--based self--study sessions. The live session will be administered by a trained mindfulness educator at the UCLA Westwood, Olive View Medical Center and Cedars--Sinai Medical Center campuses. The waitlist group will have the opportunity to participate in the same course once the study has been completed. Participants will respond to questionnaires to assess for levels of stress and other mental health measures before and after the intervention to see if the intervention group had a reduction in symptoms compared to the waitlist group.

Study Design

Study Type:
Interventional
Actual Enrollment :
82 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Impact of Mindful Awareness Practices in Pediatric Residency Training
Actual Study Start Date :
Jun 1, 2017
Actual Primary Completion Date :
Apr 30, 2018
Actual Study Completion Date :
Apr 30, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindful Awareness Practices (MAPs)

Mindful Awareness Practices is a mindfulness-based intervention developed at UCLA's Mindful Awareness Research Center. It is a weekly 2-hour, 6-session, group-based course in mindfulness meditation that is available in-person or online.

Behavioral: Mindful Awareness Practices (MAPs)
Please refer to arm description

No Intervention: Control

Waitlist control (intervention will be available to this group at the end of the study period)

Outcome Measures

Primary Outcome Measures

  1. Change in level of stress per Perceived Stress Scale (PSS) [Baseline and at 2 months (immediately post-intervention)]

    PSS = validated 14-item self-report questionnaire of stress experienced over past month. Scores range from 0-56. Higher scores represent a worse outcome.

Secondary Outcome Measures

  1. Change in symptoms of burnout per Abbreviated Maslach Burnout Inventory-9 [Baseline and at 2 months (immediately post-intervention)]

    Physician-specific self-report questionnaire of symptoms of burnout. The inventory is divided into three subscales: emotional exhaustion, depersonalization and personal accomplishment. Each subscale scores from 0-18. The subscales are reported separately rather than added together for a total score. Higher scores represent a worse outcome, except on the personal accomplishment subscale, where higher scores represent better outcome.

  2. Change in symptoms of depression per Beck Depression Inventory (BDI) [Baseline and at 2 months (immediately post-intervention)]

    Validated self-report questionnaire of symptoms of depression. Scores range from 0-63. Higher scores represent a worse outcome.

  3. Change in symptoms of anxiety per Beck Anxiety Inventory (BAI) [Baseline and at 2 months (immediately post-intervention)]

    Validated self-report questionnaire of symptoms of anxiety. Scores range from 0-63. Higher scores represent a worse outcome.

  4. Change in level of loneliness per UCLA Loneliness Scale [Baseline and at 2 months (immediately post-intervention)]

    Validated self-report questionnaire of frequency of feeling lonely. Scores range from 20-80. Higher scores represent a worse outcome.

  5. Change in level of sleep quality per Pittsburgh Sleep Quality Index (PSQI) [Baseline and at 2 months (immediately post-intervention)]

    Validated self-report questionnaire evaluated sleep quality. Scores range from 0-21. Higher scores represent a worse outcome.

  6. Change in level of mindfulness per Mindful Attention Awareness Scale (MAAS) [Baseline and at 2 months (immediately post-intervention)]

    MAAS = validated 15-item self-report questionnaire of tendency to be attentive to and aware of experiences in daily life. Scores range from 15-90. Higher scores represent a better outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Pediatric resident at the University of California Los Angeles's Mattel Children's Hospital

  • Medicine/Pediatric resident at University of California Los Angeles's Mattel Children's Hospital

Exclusion Criteria:

-None

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California, Los Angeles Los Angeles California United States 90095

Sponsors and Collaborators

  • University of California, Los Angeles

Investigators

  • Study Director: Michael Irwin, MD, University of California, Los Angeles

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Denise Rita Purdie, MD, FAAP, Principal Investigator, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT03613441
Other Study ID Numbers:
  • 16-001817
First Posted:
Aug 3, 2018
Last Update Posted:
Aug 3, 2018
Last Verified:
Aug 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Denise Rita Purdie, MD, FAAP, Principal Investigator, University of California, Los Angeles
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2018